Benzinga Pro's 5 Stocks To Watch Today

Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!

salesforce.com, inc. CRM stock was trading higher by around 5 percent early Wednesday morning in reaction to a non-GAAP first-quarter earnings beat along with a strong second quarter and full-year 2019 sales guidance.

Aslan Pharmaceuticals ADR ASLN was trading higher by more than 5 percent on top of Tuesday's 14 percent gain. The clinical-stage biopharmaceutical company targeting cancers received bullish coverage from Street analysts, including H.C. Wainwright who initiated coverage of the stock with a Buy rating and $12 price target.

CorMedix Inc. CRMD was trading higher by around 30 percent in reaction to a Phase 3 update. The biopharmaceutical company that focuses on treating infectious and inflammatory diseases said it reviewed and source-verified more than 75 percent of data for the interim analysis of its Phase 3 LOCK-IT 100 study for Neutrolin. Management expects to fully complete this work by the end of June.

Movado Group, Inc MOV was trading higher by more than 10 percent in reaction to a first-quarter earnings bet and an upward revision of its sales and EPS outlook for fiscal 2019.

Michael Kors Holdings Ltd KORS was trading lower by around 4 percent despite reporting a fiscal fourth-quarter beat and upbeat first-quarter guidance.

Related Links:

20 Stocks Moving In Wednesday's Pre-Market Session

Benzinga's Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data